|
Christian Conference of Asia
|
About CCA
Program Clusters: Special Programs:
|
The Independent, London
03 June 2003 Billions for war on Aids will go to drug firms, say activists By John Lichfield Leaders of the world's richest countries have agreed to provide billions of dollars to help fight Aids in Africa at the G8 summit but yesterday campaigners said that under present trade rules much of that cash would go to multinational pharmaceutical companies. To the disappointment of pressure groups monitoring the summit, the leaders failed to make progress on new trade rules to allow poor countries to buy cheap, generic versions of new medicines, including the drugs that can arrest Aids. France, as the summit host, had been pushing for an agreement in principle that existing rules, which forbid Third World countries from buying cheap versions of the drugs from other developing countries, should be relaxed. President Jacques Chirac's spokes-woman, Catherine Colonna, said progress was made on the issue. She explained that there was an "agreement to agree" at the next round of trade talks in Cancun in Mexico in the autumn. The United States, in particular, objects to a dilution of the international law on copyright, which would allow Third World countries, unable to make their own generic drugs, to buy them cheaply from developing nations such as Brazil. President George Bush announced before the Evian summit began that the US would give $15bn (£9.2bn) over five years to help to fight Aids in the world's poorest countries, especially in Africa. European Union countries agreed on Sunday to try to match the pledge. Speaking from Evian yesterday, Nathan Ford, the medical director of Médécins sans Frontières in the UK, said the new money was welcome but a change in copyright law would be even more useful. It would help to make cheap drugs available to Third World countries to fight not only Aids but a host of other diseases. Under present rules, he said, a poor country might have to spend $1,500 (£920) a year to treat one HIV-infected person with brand name antiretroviral drugs. Generic medicines could reduce the cost to £185 a year per person. In other words, Mr Ford explained, without a change in the trade rules, much of the money offered by America and Europe would simply come back to the large American and European pharmaceutical corporations. posted by cbs on Wednesday, June 04, 2003 |
| Archives: |
|
April 2003 /
May 2003 /
June 2003 /
July 2003 /
October 2003 /
November 2003 /
January 2004 /
February 2004 /
March 2004 /
April 2004 /
May 2004 /
July 2004 /
August 2004 /
November 2004 /
December 2004 /
January 2005 /
February 2005 /
March 2005 /
July 2005 /
January 2006 /
February 2006 /
March 2006 /
June 2006 /
August 2008 /
April 2009 /
June 2009 /
November 2009 /
December 2009 /
January 2010 /
February 2010 /
May 2010 /
June 2010 /
August 2010 /
September 2010 /
October 2010 /
November 2010 /
May 2011 /
June 2011 /
August 2011 /
September 2011 /
October 2011 /
November 2011 /
December 2011 /
February 2012 /
July 2012 /
August 2012 /
November 2012 /
|
